The functionality of immune cells is manipulated within the ocular microenvironment to protect the sensitive and non-regenerating light-gathering tissue from the collateral damage of inflammation. This is mediated partly by the constitutive presence of immunomodulating neuropeptides. Treating primary resting macrophages with soluble factors produced by the posterior eye induced co-expression of Arginase1 and NOS2. The neuropeptides alpha-melanocyte stimulating hormone and Neuropeptide Y alternatively activated the macrophages to co-express Arginase1 and NOS2 like myeloid suppressor cells. Similar co-expressing cells were found within healthy, but not in wounded retinas. Therefore, the healthy retina regulates macrophage functionality to the benefit of ocular immune privilege.
Introduction
The ocular microenvironment has adapted several mechanisms of immunomodulation to protect its delicate light-gathering tissues from the collateral damage of inflammation. These mechanisms actively manipulate immune cells away from inflammatory pathways, and induce immune regulation and tolerance (Hara et al., 1993; Kitaichi et al., 2005; Sonoda et al., 2005; Sugita et al., 2006; Taylor, 2009; Taylor et al., 1997) . The mediators are in part soluble neuropeptides produced by the cells of the ocular microenvironment that make up the blood-ocular barrier, iris, ciliary body, and retina (Cousins et al., 1991; Kaiser et al., 1989; Namba et al., 2002; Taylor et al., 1998) . Understanding the mechanisms of immunomodulation within the healthy ocular microenvironment can help find ways to suppress the damaging immunological activity of inflammation associated with autoimmune diseases, unregulated wound repair, and transplantation graft rejection.
We have recently discovered that several neuropeptides produced by retinal pigment epithelial (RPE) cells suppress endotoxin-induced activity in monocytic leukemic cell lines (Lau and Taylor, 2009; Zamiri et al., 2006) . The effects are not just suppression of proinflammatory cytokine production, but also induction of IL-10. Moreover, two suppressors of inflammation within the ocular microenvironment, alpha-melanocyte stimulating factor (α-MSH), and pigment epithelial derived factor (PEDF), are known to induce IL-10 production in endotoxin-stimulated macrophages (Zamiri et al., 2006) . This suppression of endotoxin-stimulated activity is not complete. The induction of nitric oxide stimulated by endotoxin is not suppressed, but augmented by α-MSH produced by the RPE (Lau and Taylor, 2009). In addition, RPE induce F4/80 + macrophages to be tolerogenic antigen presenting cells (Streilein et al., 2002; Zamiri et al., 2005) . These findings have demonstrated that the healthy RPE monolayer promotes immune privilege by regulating macrophage functionality. Since several immunomodulators produced by RPE stimulate immunosuppressive activity in macrophages, we tested for the possibility that retinal macrophages and microglial cells are manipulated to mediate immunosuppression within the ocular microenvironment. We found that functionality, and survival of primary macrophages was mediated by RPE derived neuropeptides α-MSH and Neuropeptide Y (NPY). Moreover, the retinal microglial cells have characteristics similar to myeloid suppressor cells that are lost in wounded retinas.
Materials and methods

Mice
Female C57BL/B6J mice, 6-8 weeks old, were obtained from Jackson Laboratories (Bar Harbor, ME). Pro-opiomelanocortin hormone (POMC) knockout mice, 8 weeks old, were bred in the animal E-mail address: awtaylor@bu.edu (A.W. Taylor).
